6 results
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Erythematosus (SLE ... Puncture, EEG Treatment ... Erythematosus #SLE ... CNS #neurology #rheumatology ... #management #treatment
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
Measurement in SLE ... half-life = 40 days ... #rheumatology # ... pharmacology #levels ... #lupus #management
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
the 3 main drug classes ... patients genotype, treatment ... cirrhosis status to see ... ambcarerx #HCV #Medications ... #DAAs #Pharmacology
Drug Induced Systemic Lupus Erythematosus
> 100 drugs have been associated with drug-induced SLE
High risk (>5%):
 •
Induced Systemic Lupus ... for 1 year of treatment ... Erythematosus #medications ... #drugs #pharmacology ... differential #diagnosis #rheumatology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
overlaps with RA, SLE ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Sjogrens #Syndrome #Rheumatology ... #Diagnosis #Management
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
mg PO TID for 3 days ... interactions with ARV (see ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology